Repeated ruptures of corpus luteum in a female patient with alpha1-antitrypsin Pittsburgh

[1]  X. Ruan,et al.  The first family group of α1-AT-P in the world with repeated hematomas: 10-year follow-up , 2019, Climacteric : the journal of the International Menopause Society.

[2]  J. Su,et al.  Clinical characteristics of two patients with α1‐antitrypsin Pittsburgh in a Chinese family , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  C. Frère,et al.  α1‐antitrypsin Pittsburgh and plasmin‐mediated proteolysis , 2016, Journal of thrombosis and haemostasis : JTH.

[4]  Juan Xiao,et al.  [Recurrent bleeding tendency in a school-aged boy]. , 2016, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[5]  Longfei Wang,et al.  [A case of recurrent bleeding disease caused by α1 antitrypsin gene Pittsburgh mutation]. , 2015, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[6]  E. Tuddenham,et al.  α1-antitrypsin Pittsburgh in a family with bleeding tendency , 2009, Haematologica.

[7]  J. Emmerich,et al.  Mechanism of protein C deficiency in a patient with arginine 358 alpha 1-antitrypsin (Pittsburgh mutation): role in the maintenance of hemostatic balance. , 1995, Journal of Laboratory and Clinical Medicine.

[8]  D. Vidaud,et al.  Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency. , 1992, The Journal of clinical investigation.

[9]  R. Bischoff,et al.  Inhibition of activated protein C by recombinant alpha 1-antitrypsin variants with substitution of arginine or leucine for methionine358. , 1990, The Journal of biological chemistry.

[10]  J. Griffin,et al.  Physiologic inhibition of human activated protein C by alpha 1-antitrypsin. , 1988, The Journal of biological chemistry.

[11]  W. Doesburg,et al.  Patterns of changes in proteins in the peritoneal fluid of women during the periovulatory phase of the menstrual cycle. , 1986, Journal of reproduction and fertility.

[12]  M. Schapira,et al.  Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment. , 1986, The Journal of clinical investigation.

[13]  J H Lewis,et al.  Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. , 1983, The New England journal of medicine.

[14]  J. Lewis,et al.  Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease. , 1978, Blood.